- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, April 26, 2019
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
A study published in the February issue of The American Journal of Managed Care® (AJMC®) was highlighted in an article in The Atlantic. The study, “Value-Based Arrangements May Be More Prevalent Than Assumed,” surveyed senior representatives from payer organizations and biopharmaceutical manufacturers to better understand the prevalence of value-based payment arrangements (VBAs) in the United States. The results showed that the majority of VBAs are not publicly disclosed, which could lead to underestimates of their true prevalence and impact.
An article from Genetic Engineering & Biotechnology News covered the panel discussion during AJMC®’s Institute for Value-Based Medicine held April 16 in White Plains, New York. During the panel discussion, “Advancing Quality Oncology Care in the Evolving Value-Based Care Landscape,” panelists discussed how payers are engaging with oncology providers in value-based care models, successfully managing high-risk patients, and more.
The National Pharmaceutical Council’s Tuesday CER Daily Newsfeed included the AJMC® article, “HHS Announces 5 New Primary Care Payment Models to Encourage Value-Based Care,” which covered the announcement from HHS Secretary Alex Azar and CMS Administrator Seema Verma that the administration is launching 5 new Medicare primary care payment models designed to eventually incentivize the entire healthcare system to transition to value-based care, particularly for patients with chronic conditions.
OBR Oncology’s Wednesday newsfeed included an article from AJMC®’s sister site The Center for Biosimilars®. The article, “Biosimilar Filgrastim Similar to Reference Product When Used in NSCLC,” covered new data from a subset analysis of MONITOR-GCSF, which showed that biosimilar filgrastim has similar effectiveness and safety to reference filgrastim.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
